The Skinny
Average Recovery
2 weeks
Permanence
Temporary
Application
Injected
Surgical
No
Cost
$350 - $750
The Specifics
What is Tirzepatide?
Tirzepatide manufactured by Eli Lilly and sold under the brand names Mounjaro and Zepbound is an FDA approved injectable medication used to treat type 2 diabetes and obesity.
What cosmetic/health concerns does Tirzepatide address?
Tirzepatide is an injectable weight loss and blood sugar lowering medication used to treat overweight individuals, obesity, and type 2 diabetes.
Who is the ideal candidate for Tirzepatide?
The ideal candidate for Tirzepatide is an individual looking for an effective weight loss and blood sugar reduction medication to complement their reduced calorie diet and physical activity regimen.
What is the average recovery associated with Tirzepatide?
Most individuals do not require any recovery from Tirzepatide injections. Some people may experience increased side effects in the day or two following an injection.
What are the potential side effects of Tirzepatide?
Possible side effects of tirzepatide injections include short term side effects like nausea, vomiting, diarrhea, constipation, and injection site reactions. Severe side effects include pancreatitis, hypoglycemia, thyroid cancer, gallbladder problems, hypoglycemia, and allergic reaction.
What can someone expect from the results of Tirzepatide?
The results of Tirzepatide injections will become noticeable after 1 month of weekly injections. Results will continue to evolve over the months and individual takes the medication.
What is the average cost of Tirzepatide?
With insurance coverage patients may pay nothing for Tirzepatide. Without insurance costs range from $350 to $750 per month depending on the mg dose.
Is it worth it?
When considering if Tirzepatide is worth it, it is important to consider the risk/benefit of the injections. While effective, Tirzepatide can have severe and life threatening side effects. Tirzepatide should always be used under the supervision of a healthcare provider.
Pros
- - Insurance Will Cover In Many Cases - Effective And Simple To Administer
Cons
- - Numerous Side Effects - Lack Of Long Term Clinical Trials Specifically Around Weight Loss
Invasiveness Score
Invasiveness is graded based on factors such as anesthesia practices, incisions, and recovery notes common to this procedure.
What to Expect
Tirzepatide manufactured by Eli Lilly and sold under the brand names Mounjaro and Zepbound is an FDA approved injectable medication used to treat type 2 diabetes and obesity.
